Lincoln Pharmaceuticals to review quarterly results at board meeting on August 13, 2026 Back

Lincoln Pharmaceuticals Limited will hold a board meeting on August 13, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, both standalone and consolidated, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited. Trading window for the company's securities has been closed since July 1, 2026, and will reopen 48 hours after the results are generally available.